Title: Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)
Authors: last_name: Drakos
first_name: E
name: E Drakos
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Singh
first_name: R R
name: R R Singh
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Rassidakis
first_name: G Z
name: G Z Rassidakis
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
label: 2
institution: First Department of Pathology, National and Kapodistrian University of Athens
country: Greece
name: First Department of Pathology, National and Kapodistrian University of Athens , Athens, Greece
last_name: Schlette
first_name: E
name: E Schlette
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Li
first_name: J
name: J Li
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Claret
first_name: F X
name: F X Claret
affiliations: label: 3
institution: Department of Systems Biology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Systems Biology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Ford
first_name: R J
name: R J Ford
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Vega
first_name: F
name: F Vega
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
last_name: Medeiros
first_name: L J
name: L J Medeiros
affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
Affiliations: label: 1
institution: Department of Hematopathology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Hematopathology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
label: 2
institution: First Department of Pathology, National and Kapodistrian University of Athens
country: Greece
name: First Department of Pathology, National and Kapodistrian University of Athens , Athens, Greece
label: 3
institution: Department of Systems Biology, The University of Texas MD Anderson Cancer Center
country: USA
name: Department of Systems Biology, The University of Texas MD Anderson Cancer Center , Houston, TX, USA
Field: Medicine
Document type: article
Year: 2011